Mechanisms of high-level ceftolozane/tazobactam resistance in Pseudomonas aeruginosa from a severely neutropenic patient and treatment success from synergy with tobramycin.

Icon for Silverchair Information Systems Related Articles

Mechanisms of high-level ceftolozane/tazobactam resistance in Pseudomonas aeruginosa from a severely neutropenic patient and treatment success from synergy with tobramycin.

J Antimicrob Chemother. 2018 Oct 08;:

Authors: So W, Shurko J, Galega R, Quilitz R, Greene JN, Lee GC

PMID: 30295837 [PubMed - as supplied by publisher]